ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,931Medicare Part D Prescriptions Filled, Including Refills

Rank: 294 out of 944

$368K Total Retail Price of All Prescriptions

Rank: 389 out of 944

486 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 486 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 486 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 6,888 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 516 441 1 1
LEVOTHYROXINE SODIUM 474 404 2 2
ENALAPRIL MALEATE 215 207 3 43
POTASSIUM CHLORIDE 201 182 4 15
ALENDRONATE SODIUM 201 194 4 20
HYDROCHLOROTHIAZIDE 200 185 6 9
AMLODIPINE BESYLATE 199 186 7 5
ATENOLOL 195 180 8 11
OMEPRAZOLE 183 145 9 4
ATORVASTATIN CALCIUM 178 169 10 13
FUROSEMIDE 176 158 11 6
WARFARIN SODIUM 169 163 12 7
LOVASTATIN 157 157 13 26
DONEPEZIL HCL 152 152 14 24
HYDROCODONE-ACETAMINOPHEN 144 121 S3 15 10
GABAPENTIN 139 101 16 18
NAMENDA 127 124 17 37
FLUOXETINE HCL 124 100 18 48
LISINOPRIL 121 96 19 3
ENALAPRIL-HYDROCHLOROTHIAZIDE 118 106 20 265
METOPROLOL TARTRATE 106 101 21 8
CELEBREX 97 90 22 110
SERTRALINE HCL 93 63 23 23
CITALOPRAM HBR 88 76 24 19
METFORMIN HCL 87 81 25 12
MIRTAZAPINE 82 79 26 35
ALLOPURINOL 81 67 27 22
LOSARTAN-HYDROCHLOROTHIAZIDE 77 76 28 54
TRIAMTERENE-HCTZ 76 69 29 33
ZOLPIDEM TARTRATE 72 45 30 25
FLUTICASONE PROPIONATE 72 46 30 40
MELOXICAM 70 60 32 68
EVISTA 67 55 33 172
LOSARTAN POTASSIUM 66 66 34 16
ADVAIR DISKUS 66 54 34 31
TRAMADOL HCL 61 59 36 21
GLYBURIDE-METFORMIN HCL 59 59 R 37 132
ZETIA 55 44 38 59
DIOVAN 54 54 39 38
BENAZEPRIL HCL 53 43 40 66
PREDNISONE 50 38 41 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.